PriceTargets.com logo

Leerink Partnrs Stock Recommendations and Price Targets

This is a list of recent ratings by Leerink Partnrs.

DateCompany NameActionCurrent
Price		Price
Target		RatingImpact on
Share Price
3/24/2025
OPT
Opthea
 Downgrade$3.00Strong-Buy ➝ HoldLow
3/24/2025
MEDP
Medpace
 Upgrade$318.00HoldMedium
3/20/2025
ELEV
Elevation Oncology
 Downgrade$0.00Strong-Buy ➝ HoldLow
3/17/2025
STTK
Shattuck Labs
 Upgrade$1.00Strong-BuyMedium
3/17/2025
NRIX
Nurix Therapeutics
 Upgrade$13.00HoldLow
3/11/2025
TSVT
2seventy bio
 Downgrade$5.00Strong-Buy ➝ HoldLow
3/7/2025
CRMD
CorMedix
 Upgrade$7.00Strong-BuyLow
3/5/2025
LXRX
Lexicon Pharmaceuticals
 Downgrade$0.00Strong-Buy ➝ HoldHigh
3/3/2025
PLRX
Pliant Therapeutics
 Downgrade$1.00Strong-Buy ➝ HoldHigh
2/25/2025
MAZE
Maze Therapeutics
 Upgrade$11.00Strong-BuyHigh
2/24/2025
BBNX
Beta Bionics
 Upgrade$13.00Strong-BuyHigh
2/18/2025
ATYR
Atyr PHARMA
 Upgrade$3.00Strong-BuyHigh
2/13/2025
GMAB
Genmab A/S
 Upgrade$20.00Hold ➝ Strong-BuyLow
2/13/2025
TXG
10x Genomics
 Downgrade$10.00Strong-Buy ➝ HoldHigh
2/12/2025
CVS
CVS Health
 Upgrade$67.00Hold ➝ Strong-BuyLow
2/7/2025
DOCS
Doximity
 Upgrade$62.00Hold ➝ Strong-BuyHigh
2/6/2025
HOLX
Hologic
 Downgrade$61.00Strong-Buy ➝ HoldLow
2/5/2025
REGN
Regeneron Pharmaceuticals
 Upgrade$640.00Hold ➝ Strong-BuyLow
1/13/2025
ITCI
Intra-Cellular Therapies
 Downgrade$132.00Strong-Buy ➝ HoldLow
1/8/2025
ACCD
Accolade
 Downgrade$7.00Strong-Buy ➝ HoldLow
1/6/2025
ALGN
Align Technology
 Upgrade$166.00Hold ➝ Strong-BuyLow
1/6/2025
DGX
Quest Diagnostics
 Upgrade$167.00Hold ➝ Strong-BuyMedium
12/12/2024
LVTX
LAVA Therapeutics
 Downgrade$1.00Strong-Buy ➝ HoldN/A
12/11/2024
ANIP
ANI Pharmaceuticals
 Upgrade$67.00Strong-BuyN/A
12/11/2024
QTTB
Q32 Bio
 Downgrade$2.00Strong-Buy ➝ HoldN/A
12/11/2024
PDCO
Patterson Companies
 Downgrade$31.00Strong-Buy ➝ HoldN/A
12/9/2024
MYGN
Myriad Genetics
 Downgrade$9.00Strong-Buy ➝ HoldN/A
12/5/2024
OKUR
OnKure Therapeutics
 Upgrade$5.00Strong-BuyN/A
12/4/2024
RLMD
Relmada Therapeutics
 Downgrade$0.00Strong-Buy ➝ HoldN/A
12/2/2024
CLYM
Climb Bio
 Upgrade$1.00Strong-BuyN/A
12/2/2024
ELAN
Elanco Animal Health
 Upgrade$11.00HoldN/A
12/2/2024
ZTS
Zoetis
 Upgrade$163.00Strong-BuyN/A
12/2/2024
IDXX
IDEXX Laboratories
 Upgrade$418.00Strong-BuyN/A
11/22/2024
JANX
Janux Therapeutics
 Upgrade$30.00Strong-BuyN/A
11/22/2024
ABBV
AbbVie
 Upgrade$201.00Hold ➝ Strong-BuyN/A
11/19/2024
ACRS
Aclaris Therapeutics
 Upgrade$2.00Hold ➝ Strong-BuyN/A
11/15/2024
CMPX
Compass Therapeutics
 Downgrade$2.00Strong-Buy ➝ HoldN/A
11/13/2024
MASS
908 Devices
 Downgrade$4.00Strong-Buy ➝ HoldN/A
11/12/2024
BMY
Bristol-Myers Squibb
 Upgrade$59.00Hold ➝ Strong-BuyN/A
11/7/2024
ZYME
Zymeworks
 Upgrade$12.00Hold ➝ Strong-BuyN/A
11/7/2024
XRAY
DENTSPLY SIRONA
 Downgrade$16.00Strong-Buy ➝ HoldN/A
11/6/2024
BEAM
Beam Therapeutics
 Upgrade$22.00Hold ➝ Strong-BuyN/A
11/5/2024
IDYA
IDEAYA Biosciences
 Downgrade$17.00Strong-Buy ➝ HoldLow
11/4/2024
ZURA
Zura Bio
 Upgrade$1.00Strong-BuyHigh
10/31/2024
NVST
Envista
 Upgrade$18.00Strong Sell ➝ HoldMedium
10/24/2024
TENX
Tenax Therapeutics
 Upgrade$6.00Strong-BuyHigh
10/21/2024
GILD
Gilead Sciences
 Upgrade$109.00Hold ➝ Strong-BuyHigh
10/16/2024
VYGR
Voyager Therapeutics
 Upgrade$4.00Strong-BuyMedium
10/11/2024
MNMD
Mind Medicine (MindMed)
 Upgrade$7.00Strong-BuyMedium
10/11/2024
STOK
Stoke Therapeutics
 Upgrade$7.00Strong-BuyLow
10/7/2024
MOLN
Molecular Partners
 Upgrade$4.00Strong-BuyLow
10/2/2024
HUM
Humana
 Downgrade$270.00Strong-Buy ➝ HoldMedium
9/27/2024
AGIO
Agios Pharmaceuticals
 Downgrade$30.00Strong-Buy ➝ HoldMedium
9/24/2024
REGN
Regeneron Pharmaceuticals
 Downgrade$640.00Strong-Buy ➝ HoldMedium
9/18/2024
ICLR
ICON Public
 Upgrade$179.00Strong-BuyLow
9/17/2024
ORKA
Oruka Therapeutics
 Upgrade$11.00Strong-BuyLow
9/12/2024
FULC
Fulcrum Therapeutics
 Downgrade$3.00Strong-Buy ➝ HoldHigh
9/9/2024
IMUX
Immunic
 Upgrade$1.00Strong-BuyHigh
9/9/2024
TRVI
Trevi Therapeutics
 Upgrade$6.00Strong-BuyMedium
9/9/2024
IRWD
Ironwood Pharmaceuticals
 Upgrade$1.00HoldMedium
9/9/2024
GERN
Geron
 Upgrade$2.00Strong-BuyLow
9/9/2024
MNKD
MannKind
 Upgrade$5.00Strong-BuyMedium
9/9/2024
PLRX
Pliant Therapeutics
 Upgrade$1.00Strong-BuyLow
9/9/2024
PRTC
PureTech Health
 Upgrade$17.00Strong-BuyHigh
9/9/2024
GLPG
Galapagos
 Upgrade$25.00HoldMedium
9/9/2024
KYMR
Kymera Therapeutics
 Upgrade$30.00Strong-BuyMedium
9/3/2024
TXG
10x Genomics
 Upgrade$10.00Strong-BuyLow
9/3/2024
NARI
Inari Medical
 Upgrade$80.00HoldLow
9/3/2024
PEN
Penumbra
 Upgrade$275.00Strong-BuyLow
8/12/2024
ARCT
Arcturus Therapeutics
 Upgrade$12.00Strong-BuyLow
8/12/2024
ARDT
Ardent Health Partners
 Upgrade$13.00Strong-BuyLow
8/7/2024
PGNY
Progyny
 Downgrade$22.00Strong-Buy ➝ HoldLow
8/6/2024
TBPH
Theravance Biopharma
 Downgrade$9.00Strong-Buy ➝ HoldLow
8/1/2024
WAT
Waters
 Upgrade$367.00Hold ➝ Strong-BuyLow
7/24/2024
TECX
Tectonic Therapeutic
 Upgrade$19.00Strong-BuyLow
7/24/2024
IONS
Ionis Pharmaceuticals
 Upgrade$31.00Hold ➝ Strong-BuyLow
7/23/2024
ALMS
Alumis
 Upgrade$5.00Strong-BuyLow
7/22/2024
BNTC
Benitec Biopharma
 Upgrade$14.00Strong-BuyLow
7/22/2024
CELC
Celcuity
 Upgrade$10.00Strong-BuyLow
7/10/2024
EHC
Encompass Health
 Upgrade$100.00Strong-BuyLow
7/9/2024
HLVX
HilleVax
 Downgrade$2.00Strong-Buy ➝ HoldLow
7/8/2024
RVTY
Revvity
 Upgrade$107.00Strong-BuyLow
7/2/2024
SDGR
Schrödinger
 Upgrade$21.00Strong-BuyLow
6/24/2024
SLDB
Solid Biosciences
 Upgrade$4.00Hold ➝ Strong-BuyLow
5/21/2024
QTTB
Q32 Bio
 Upgrade$2.00Strong-BuyLow
5/14/2024
BOLT
Bolt Biotherapeutics
 Downgrade$0.00Strong-Buy ➝ HoldLow
5/14/2024
AIRS
AirSculpt Technologies
 Downgrade$3.00Strong-Buy ➝ HoldLow
5/14/2024
EHAB
Enhabit
 Upgrade$9.00Strong Sell ➝ HoldLow
5/10/2024
AQST
Aquestive Therapeutics
 Upgrade$3.00Strong-BuyLow
5/8/2024
MYGN
Myriad Genetics
 Upgrade$9.00Market Perform ➝ OutperformLow
5/6/2024
BPMC
Blueprint Medicines
 Upgrade$91.00Underperform ➝ Market PerformLow
5/1/2024
CVS
CVS Health
 Downgrade$67.00Outperform ➝ Market PerformLow
4/30/2024
LXRX
Lexicon Pharmaceuticals
 Reiterated Rating$0.00OutperformLow
4/29/2024
IMCR
Immunocore
 Reiterated Rating$29.00OutperformLow
4/29/2024
XOMA
XOMA
 Reiterated Rating$21.00OutperformLow
4/29/2024
NGNE
Neurogene
 Reiterated Rating$16.00OutperformLow
4/25/2024
CVAC
CureVac
 Downgrade$3.00Outperform ➝ Market PerformLow
4/25/2024
TNDM
Tandem Diabetes Care
 Upgrade$20.00Market Perform ➝ OutperformLow
4/23/2024
RNAC
Cartesian Therapeutics
 Reiterated Rating$15.00OutperformLow
4/16/2024
ANAB
AnaptysBio
 Reiterated Rating$18.00OutperformLow




Get Analyst Ratings Delivered To Your Inbox
Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat's FREE daily email newsletter.